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Variable Hazard ratio [95%
CI]
P value
Age (per 10 year increase) 1.58 [1.30, 1.91] <0.0001
History of diabetes mellitus 1.82 [1.27, 2.62] 0.001
History of peripheral vascular disease 1.83 [1.09, 3.07] 0.02
History of smoking 1.50 [1.05, 2.14] 0.03
History of prior myocardial infarction 1.82 [1.21, 2.72] 0.004
Baseline creatinine clearance <60 2.03 [1.35, 3.07] 0.001
Killip class 1 (vs. 2-4) 0.41 [0.28, 0.61] <0.0001
LAD infarct artery (vs. all others) 1.75 [1.13, 2.70] 0.01
Door to balloon (or ﬁrst device) (per
hour)
1.09 [0.92, 1.29] 0.32
Final TIMI 3 ﬂow (vs. 0-2) 0.49 [0.34, 0.72] <0.0001
Any IAE 1.83 [1.04, 3.21] 0.04
Demographic features and clinical outcomes in Non transfer STEMI Vs
Transfer STEMI groups





Age 62 +/- 13 60 +/- 13 0.07
Males 75% 71% 0.17
Diabetes Mellitus 21% 21% 0.8
Mean Ejection fraction 47 +/- 11 47 +/- 10 0.9
Cardiogenic shock and/or cardiac
arrest before PCI
12.8% 14.4% 0.45
Cardiogenic shock after PCI 2.8% 4.2% 0.24
CHF after PCI 2.2% 2.4% 0.85
IABP use 7.6% 7.3% 0.8
Stroke after PCI 1.2% 0.6% 0.3
Goal DTB time achieved 85% (<90 min) 33% (<120 min) <0.001
In hospital mortality 5.2% 5.3% 0.9
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: Current systems of rapid transfer and PCI in acute STEMI patients
transferred for primary PCI from non PCI facility enable these patients to have similar
short term clinical outcomes as patients presenting directly to PCI facility.
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Background: Ischemic post-conditioning (IPoC) is believed to improve the outcome
in ST elevation myocardial infarction (STEMI) undergoing primary percutaneous
intervention (PPCI) by minimizing the reperfusion injury though several trials have
shown variable results. We sought to perform a meta-analysis of randomized
controlled trials (RCTs) comparing IPoC versus standard therapy during PPCI.
Methods: PubMed, Cochrane and Web of Science databases were searched through
April 30th 2014 for RCTs comparing IPoC versus standard therapy during PPCI.
Outcomes analyzed were infract size by MRI (% of LV mass), peak cardiac bio-
markers(troponins), left ventricle ejection fraction(LVEF) by MRI & transthoracic
echo(TTE), ST segment resolution of  70% (ST70), death, myocardial infarc-
tion(MI) and subsequent revascularization. Study quality, publication bias, heteroge-
neity were assessed. Random effect model used for data analysis.
Results: 26 RCTs with 2330 patients (IPoC 1169, Control 1161) were included for the
analysis. Infarct size assessed by MRI (SMD -0.06 (p¼0.84) at 1 wk, -0.03 (p¼0.88)
at 1-6 mo), peak troponin (SMD 0.04 p¼0.91), ST70 (RR 1.04 p¼0.78) and LVEF
both by MRI (SMD 0.14 (p¼0.12) at 1wk, 0.04 (p¼0.7) at 1-6 mo) & TTE (SMD
0.28 (p¼0.1) at 1wk, 0.11 (p¼0.57) at 1-6 mo, 1.18(p¼0.06) at 1-3 yr) were similar in
both groups (IPoC versus control). Similarly there was no difference in clinical
endpoints like death (RR 1.44 p¼0.28), MI (RR 1.83 p¼0.37) and subsequent
revascularization (RR 1.2 p¼0.75).
Conclusions: IPoC compared to standard therapy is neither associated with any
signiﬁcant beneﬁt in terms of clinical outcomes nor improvement in degree of
myocardial necrosis in STEMI patients undergoing PPCI.
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Background: There is very little clinical data or speciﬁc management guidelines for
very elderly patients with ST Elevation MI (STEMI). We evaluated our practice in the
management of STEMI in patients over age 85.
Methods: A retrospective study of STEMI patients aged >85 in a PPCI (Primary
percutaneous coronary intervention) centre in the UK between April 2012-November
2013. Data was collected from Intellect, MINAP databases and discharge documents.
Results: Of the 993 patients with STEMI, 66 (6.6%) were > 85 years of age. There
were 38 males and 28 females (average age 88 (85-96) years). 35(63%) had PPCI and
31 (27%) treated medically. Inferior MI (50%) was more common than Anterior
(36%). Patients had multiple co-morbidities: Hypertension (32), smoking history (30),
Ischaemic Heart Disease (11), Hyperlipidaemia (8), Diabetes Mellitus (7) and Stroke
(6). 77% (51) were discharged alive and 23 % (11) died in hospital and a further 16%
(11) died 1 year post-discharge. In –hospital complication rate was 13 %( 8). Of 31
managed conservatively, 21 (67%) were females. Average age 89 years with multiple
co-morbidities. Presentation included dizziness, abdominal pain, feeling unwell,
vomiting and collapse. PPCI was not offered due to late presentation (>12 hours afterB14 JACC Vol 64/11/Suppl B jsymptom onset) (32%), poor prognosis, cardiogenic shock, high risk of bleeding,
resolution of symptoms and ECG and frailty. 20 (64%) were discharged alive, 7(22%)
died in the hospital and 4 transferred to a different hospital. Additional 8 (25%) died 1
year post-discharge. Complication rate was 12%. In the PPCI group (35), 24 (68%)
male patients, average age 87 years presented with typical symptoms and multiple co-
morbidities. 30(85%) of patients were discharged alive and a further (3)8.5% died
within 1 year post-discharge. Complication rate was 14%.
Conclusions: Elderly patients undergoing PPCI had better outcomes. Both groups had
multiple co-morbidities. Overall complication rate was 13%; although PPCI group had
a higher complication rate but a lower mortality 1 year post-discharge. Therefore,
PPCI has a role in treating the very elderly with STEMI, this analysis emphasises the
need for clinical trials targeted at this population.
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Background: Rapid reperfusion with primary percutaneous coronary intervention
(PCI) improves survival in patients with ST-segment elevation myocardial infarction
(STEMI). Pre-procedural cardiopulmonary instability and adverse events (IAE) may
delay reperfusion time and worsen prognosis. We set out to evaluate the relationship
between pre-procedural cardiopulmonary instability and adverse events (IAE), door-
to-balloon time (DBT), and outcomes in the HORIZONS-AMI trial.
Methods: Pre-procedural cardiopulmonary IAE included sustained ventricular or
supraventricular tachycardia or ﬁbrillation requiring cardioversion or deﬁbrillation,
heart block or bradycardia requiring pacemaker implantation, severe hypotension
requiring vasopressors or intraaortic balloon counterpulsation, respiratory failure
requiring mechanical ventilation, and cardiopulmonary resuscitation. We compared
3-year outcomes of patients with and without IAE according to DBT.
Results: Among 3,602 patients, 159 (4.4%) had at least one IAE. DBT did not differ
signiﬁcantly in patients with and without IAE; however, patients with IAE were less
likely to have TIMI 3 ﬂow after PCI. Mortality at 3 years was signiﬁcantly higher in
patients with vs. without IAE (17.0% vs. 6.3%, P< 0.0001), and IAE was an inde-
pendent predictor of mortality (see Table), whereas DBT was not. However, a sig-
niﬁcant interaction was present such that 3-year mortality was reduced in patients with
DBT < 99 minutes (the median) vs. 99 minutes to a greater extent in patients with
IAE (9.9% vs. 20.7%, HR[95%CI] ¼ 0.43 [0.16,1.16]) compared to those without
IAE (5.0% vs. 7.2%, HR ¼ 0.69 [0.50,0.95], Pinteraction¼0.004).
Conclusions: IAE prior to PCI is an independent predictor of death and identiﬁes a
high-risk group in whom faster reperfusion may be particularly important to improve
survival.TCT-48
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Background: No consensus exists about which coronary artery should be ﬁrstly
catheterized in primary PCIs. Initial catheterization of the “culprit artery” (supposed
by ECG) could reduce reperfusion time. However, knowledge of multivessel diseaseSeptember 13–17, 2014 j TCT Abstracts/Acute Myocardial Infarction
www.jacctctabstracts2014.com SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PMor left main (LM) disease could modify revascularization strategy. Aim: to analyze
this issue in patients with STEMI undergoing primary PCI.
Methods: PCIs were performed in 408 consecutive patients (63.113.6 years; 73.4%
males) by 6 different cardiologists. Choice of ipsilateral approach (IA): starting with
the supposed “culprit artery”, or a contralateral one (CA) was left to the operator.
Differences between the two approaches and their inﬂuence on reperfusion time,
events during admission or revascularization strategies were analyzed.
Results: Right coronary artery (RCA) was the responsible in 41.8% of cases, left
anterior descending in 41.5%, circumﬂex in 15.5% and LM in 1.3%. IA was preferred
in 53.06% of cases and CA in 46.94%. There were no differences between two ap-
proaches regarding baseline features of patients, reperfusion time, radiation exposure,
mortality or hospital stay. With IA a higher volume of contrast was used (189 vs 170 cc;
p¼0.018) When the left coronary artery (LCA) was the responsible, IA was more
frequent (76% IA vs 24% CA), but when it was the RCA, CA was preferred (IA 23.5%
vs CA 76.5%); p< 0.0001. With CA, bare metal stents (BMS) were more used than
drug eluting (BMS 53.8% vs DES 34.6%) inversely than with IA (BMS 39.3% vs DES
55.7%); p< 0.0001. With CA there were more patients with LM or multivessel disease
in which revascularization was completed with surgery (4.13% vs 2.4%, p< 0.0001).
Conclusions: Initial CA does not involve higher reperfusion time or clinical events.
On the contrary, the overall knowledge of coronary anatomy could imply a change in
management: greater use of BMS and programmed cardiac surgery. Moreover, ECG is
not always deﬁnitive to determine the culprit artery, speciﬁcally in inferior myocardial
infarctions. Despite the need to individualize each case, contralateral approach may be
the ﬁrst option with the exception of unstable patients.
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Background: Myocardial reperfusion following primary percutaneous coronary
intervention (PPCI) is limited due to atheroembolic events in patients with ST-
segment elevation myocardial infarction (STEMI). We aimed to evaluate the impact of
direct stenting technique on myocardial reperfusion and clinical outcomes of patients
with STEMI undergoing primary angioplasty (PCI).
Methods: Consecutive 78 patients were randomly assigned to the direct stenting or
the balloon predilatation after TIMI 2 or 3 ﬂow is achieved by selective aspiration
thrombectomy Epicardial and myocardial patency were assessed according to
Thrombolysis In Myocardial Infarction (TIMI) ﬂow scale and TIMI myocardial
perfusion (TMP) grade. Index of microcirculatory resistance (IMR) was assessed with
thermodilution curves during maximal hyperemia immediately after PCI. One year
clinical outcome was compared.
Results: A total of 78 patients were randomized after exclusion of patients not suitable
for stenting. Direct stenting was feasible in 34 of 39 patients who were initially
randomized (DS group) and stenting after balloon predilation was done to 39 patients
(PB group). There were no signiﬁcant differences in epidemiologic parameters, pain-
to-treatment time, and use of Glycoprotein IIb/IIIa Inhibitor. Final TIMI grade 3 ﬂow
(93.1% vs 82.1 %, p¼0.25), ﬁnal TMP grade 3 (64.3% vs 58.6%, p¼0.6) and peak
CK-MB level (178 vs. 190 ng/dL, p¼0.73) were comparable between DS and PB
group. IMR was similar between DS and PB group (23.3 vs. 29.4 mmHg∙sec,
p¼0.38). IMR could not be measured in 5 patients, including 1 in DS and 4 in PB
group, due to cardiogenic shock after stenting. At one year, 3 cardiac death had
occurred in PB group (0% vs 7.7 %, p ¼ 0.24).
Conclusions: DS without predilation after TA is not inferior to PB during PPCI in
improving myocardial perfusion and has a tendency of better clinical outcome. When
anatomically and technically feasible, DS technique may be considered.
TCT-50
In-Hospital Outcomes of Routine Early Post-Thrombolysis Percutaneous
Coronary Intervention in Acute ST-Elevation Myocardial Infarction
Igor Zyrianov1, Ivan Bessonov1, Vadim Kuznetsov1, Stanislav Sapozhnikov1,
Anastasia Takkand1
1Tyumen cardiology center, Tyumen, Russian Federation
Background: Pre-hospital thrombolysis is associated with reduced time delay.
Routine early PCI after thrombolysis may optimize reperfusion and prevent rein-
farction and recurrent ischemia. The aim of this study was to evaluate in-hospital
outcomes of routine early PCI after prehospital tenecteplase thrombolysis in patients
with acute ST-elevation myocardial infarction in real-world clinical practice.
Methods: Data were collected on all patients (n ¼ 721) with STEMI admitted to the
coronary care unit and submitted to primary PCI from 2008 to 2013. One hundred
forty-four patients (20%) received routine early post-thrombolysis PCI were compared
with 577 patients received primary PCI. The composite of in-hospital death,
myocardial infarction, and stent thrombosis deﬁned as major adverse cardiac events
(MACE) were deﬁned as primary endpoints.
Results: Patients received routine early post-thrombolysis PCI were signiﬁcantly
younger then patients primary PCI group (56.910.2 years versus 59.611.2, p¼0.01).
The rate of diabetes mellitus, dyslipidemia, hypertension, chronic kidney disease and
previous MI were comparable between groups. The culprit artery was more often theJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/AcLAD in patients received routine early post-thrombolysis PCI (81.3% versus 46.6%, p<
0.001). The median “pain to needle” time was 80 minutes in patients after prehospital
thrombolysis group. The median time from thrombolysis to PCI was 4.5 hours. The
median “door-to-balloon” time was 86 minutes in primary PCI group. The rate of
transradial approach was comparable between groups (56.3% vs 57.2%; p¼0.838).
Occluded culprit arteries were more rarely identiﬁed during routine early PCI after
prehospital thrombolysis (41.7% vs 71.4%; p< 0.001). There were no difference of rates
of failed PCI (5.2% vs 3.5%; p¼0.388) and access site complications (4.9% vs 6.6%;
p¼0.564). The rate of stent thrombosis (3.5% vs 1.6 %; p¼0.127), repeat myocardial
infarction (2.1% vs 0.9%; p¼0.202), death (2.8% vs 3.5%; p¼0.459) as well as MACE
(7.6% vs 8.1%; p¼0.841) were comparable between groups.
Conclusions: In real-world clinical practice in-hospital outcomes of routine early
PCI after prehospital thrombolysis were comparable with primary PCI in acute
ST-elevation myoc.
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Background: Asymptomatic patients with chronic kidney disease (CKD) often
exhibit elevated levels of cardiac troponins. Therefore, we hypothesized that the
systemic release of troponin after ﬁrst ST-elevation myocardial infarction (STEMI)
will be disproportionally higher than that of creatine kinase (CK) in patients with
CKD.
Methods: We retrospectively reviewed consecutive 480 patients with STEMI from
January 2007 to August 2013. Among 480 patients, 203 patients were excludedd30
had a prior history ofmyocardial infarction, 25 did not result in CK elevation and 148 did
not have sufﬁcient data for analysis. Troponin I and CK levels were measured at 6-hour
intervals. The peak troponin to peak CK ratio (TCR) was calculated. High TCR was
deﬁned as TCR greater than 1SD. CKD was deﬁned as estimated glomerular ﬁltration
rate< 60ml/min/1.73m2 based on the creatinine value on admission. Echocardiography
was performed before discharge. Non-obstructive coronary artery was deﬁned as less
than 50% stenosis. Clinical characteristics and echocardiographic ﬁndings were
compared between the patients with and without CKD.
Results: Among 277 patients, 56 (20.2%) patients had CKD and 35 (12.6%) had high
TCR. Patients with CKD had a higher prevalence of hypertension, diabetes and
hyperlipidemia. Peak troponin I levels were higher in the CKD group compared to the
patients without CKD (median 95.3 [25-75%: 42.4-159.5] ng/mL vs. 57.1 [25-75%:
27.2-138.0] ng/mL, p¼0.03). In contrast, there was no signiﬁcant difference in peak
CK value (median 2252 [25-75%: 1012-3690] U/L vs. 2166 [25-75%: 951-3857] U/L,
p¼0.81), or left ventricular ejection fraction (median 44% [25-75%: 30-60%] vs. 50%
[25-75%: 38-60%], p¼0.07) between the two groups. High TCR was associated with
CKD (p< 0.001) and echocardiographic left ventricular hypertrophy (p¼0.01), but not
with hypertension, diabetes or hyperlipidemia.
Conclusions: Peak troponin level after ﬁrst STEMI was higher in patients with CKD
compared to patients without CKD, whereas peak CK level and left ventricular ejection
fraction were comparable between the patients with and without CKD. Therefore, peak
troponin level may overestimate infarct size after ﬁrst STEMI in patients with CKD.
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Background: The effects of collateral circulation between choronic total occlusion
(CTO) and infarct related artery (IRA) in acute ST elevation myocardial infarction
(STEMI) remains unknown. We aimed to assess the inﬂuence of this connection on
early clinical outcomes after primary percutaneous coronary intervention (PPCI) in
acute STEMI.
Methods: FromMarch 2013 throughMay 2014, a total of 534 consecutive acute STEMI
patients who underwent PPCI were enrolled the study. After PPCI, 62 (11.6%) patients
with concurrent CTO were divided in two groups. Accordingly, after restoration of
antegrad ﬂow, the new appearance collateral circulation to the CTO were classiﬁed as
CTO-IRA connected group. The others were classiﬁed as CTO-IRA unconnected group.
Results: In this study, we found the adverse effects of collateral circulation in CTO-IRA
connected group. This group was associated with higher incidence of Killip class2 at
presentation, lower rate of post procedural thorombolysis in myocardial infarction
(TIMI) 2/3 ﬂow and myocardial blush grade (MBG) 3 than CTO-IRA unconnected
group. Theseﬁndings also reﬂected as lower ejection fraction and higher peak troponin T
levels. In addition we found that CTO-IRA connected group had signiﬁcantly higher in
hospital and 30-day mortality rate (62.5%; p< .001, 70%; p< .001, respectively ). If we
excluded the CTO-IRA connected group, early mortality rates became similar in acute
STEMI patients with and without coexisting CTO group (p¼.179).
Conclusions: After restoration of antegrade blood ﬂow in PPCI, detectable collaterals
from IRA to CTO has an unfavourable effect on procedural success, enzymatic infarct
size, pre- and post procedural haemodynamic conditions in acute STEMI patients.
Furthermore these collaterals can predict the early clinical outcome.ute Myocardial Infarction B15
